N^2^-(4-Aminobutyryl)-L-lysine hydrolase
RxNorm 98090
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 98090 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: N^2^-(4-Aminobutyryl)-L-lysine hydrolase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Aminoacyl-lysine dipeptidase
(Atom ID: 732706)
FN
Full form of descriptor (FN):
Aminoacyl-lysine dipeptidase (substance)
(Atom ID: 732712)
SY